Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription 19.02.2024 2 BMC Gastroenterol 2 Clin Res Hepatol Gastroenterol 3 Dig Dis Sci 2 Hepatology 1 J Gastroenterol Hepatol 2 J Hepatol 1 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. ZHOU Y, Liang M, Li Y, Chen X, et al
   Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.
   BMC Gastroenterol. 2024;24:73.
   PubMed         Abstract available
   
   
2. HARI A, Stabuc B
   Possible use of 2D shear wave liver elastography in new-onset ascites evaluation.
   BMC Gastroenterol. 2024;24:68.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

3. HE Q, Xiong Y, Xia P, Yang X, et al
   Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
   Clin Res Hepatol Gastroenterol. 2024;48:102283.
   PubMed         Abstract available
   
   
4. XIE C, Liu K, Xie Y, Liu S, et al
   Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease.
   Clin Res Hepatol Gastroenterol. 2024;48:102264.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

5. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
   Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
   Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
   PubMed         Abstract available
   
   
6. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
   Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
   Dig Dis Sci. 2024;69:643-644.
   PubMed        
   
   
7. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
   Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
   Dig Dis Sci. 2024;69:370-383.
   PubMed         Abstract available
   
   

   
   Hepatology

8. 
   Erratum: An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations.
   Hepatology. 2024;79:E105.
   PubMed        
   
   
9. AGRAWAL D, Ariga KK
   Liver, heart, and kidney crosstalk in cirrhosis: POCUS is the focus.
   Hepatology. 2024 Feb 14. doi: 10.1097/HEP.0000000000000789.
   PubMed        
   
   

   
   J Gastroenterol Hepatol

10. SHI L, Feng G, Yang X, Zhang Y, et al
    Potential of PAQosome as a therapeutic target for hepatic fibrosis.
    J Gastroenterol Hepatol. 2023 Nov 28. doi: 10.1111/jgh.16427.
    PubMed         Abstract available
    
    

    
    J Hepatol

11. ARTRU F, Reiberger T
    One - or more - blind spot(s) unveiled in the new definition of decompensated cirrhosis.
    J Hepatol. 2024 Feb 8:S0168-8278(24)00118-1. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    
12. HUANG CH, Tsai MH, Lin CY
    Identifying the pivotal role of non-acute decompensation as a precursor to acute decompensation in cirrhosis.
    J Hepatol. 2024 Feb 7:S0168-8278(24)00119-3. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    N Engl J Med

13. HARRISON SA, Bedossa P, Guy CD, Schattenberg JM, et al
    A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
    N Engl J Med. 2024;390:497-509.
    PubMed         Abstract available
    
    

    
    PLoS One

14. LIU Z, Shao Y, Duan X
    Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298225.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.